122 results
Page 4 of 7
424B5
pt4k k6aomj
11 Feb 22
Prospectus supplement for primary offering
5:28pm
6-K
EX-99.3
rbwuqh
15 Nov 21
VBL Therapeutics Reports Third Quarter 2021 Financial Results
7:00am
6-K
iboqrllq
16 Aug 21
Current report (foreign)
7:00am
6-K
05us882ba 6o1ck2
11 May 21
Current report (foreign)
7:00am
424B8
ei4dy4f
19 Apr 21
Prospectus unintentially filed late
5:06pm
6-K
EX-1.1
dt2tcoxbzj
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-4.1
livfom4 ap5ohbdqbo3
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
424B5
v1748uu5zdgjhpxzdcr
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
k6yq rtt00iu
9 Apr 21
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
c87t6dzuv ce3ej7w9vj
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
424B5
2xhrtfis6d9vlhom6d
15 Jan 21
Prospectus supplement for primary offering
7:00am
F-3
a6xecf3if2z2 kahe48w
30 Dec 20
Shelf registration (foreign)
4:17pm
424B3
62rvv0g13ui0p
16 Nov 20
Prospectus supplement
7:15am
6-K
gi5wjpcr
16 Nov 20
Current report (foreign)
7:00am
424B3
fc2etne btprwnb
26 Aug 20
Prospectus supplement
5:21pm
6-K
d30ppz51gjmgk5b6
13 Aug 20
Current report (foreign)
7:00am
S-8
EX-5.1
rt1r0pqk37v8lgkmh
5 Aug 20
Registration of securities for employees
4:31pm
6-K
xg091x 1x8hltfxlubs
14 May 20
Current report (foreign)
7:25am
6-K
EX-4.1
jtshz9lk82ga5k36m7
12 May 20
Current report (foreign)
12:04pm